DDrare: Database of Drug Development for Rare Diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
298	遺伝性膵炎	1

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00630279 (ClinicalTrials.gov)	February 2008	22/2/2008	Dose-ranging Study to Evaluate Efficacy of SLV339 in Pancreatic Exocrine Insufficiency Due to Chronic Pancreatitis	A Multi-center, Single-blind, Parallel-design, Randomized, Placebo-controlled, Dose-ranging Study to Evaluate Oral Recombinant Microbial Lipase Efficacy in Patients With Pancreatic Exocrine Insufficiency Due to Chronic Pancreatitis	Pancreatic Exocrine Insufficiency Due to Chronic Pancreatitis	Drug: Placebo;Drug: Recombinant Microbial Lipase SLV339	Solvay Pharmaceuticals	NULL	Terminated	18 Years	N/A	Both	56	Phase 2	Czech Republic;Denmark;Hungary;Latvia;Poland;Russian Federation;Sweden

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

NCT00630279
(ClinicalTrials.gov)

February 2008

22/2/2008

Dose-ranging Study to Evaluate Efficacy of SLV339 in Pancreatic Exocrine Insufficiency Due to Chronic Pancreatitis

A Multi-center, Single-blind, Parallel-design, Randomized, Placebo-controlled, Dose-ranging Study to Evaluate Oral Recombinant Microbial Lipase Efficacy in Patients With Pancreatic Exocrine Insufficiency Due to Chronic Pancreatitis

Pancreatic Exocrine Insufficiency Due to Chronic Pancreatitis

Drug: Placebo;Drug: Recombinant Microbial Lipase SLV339

Solvay Pharmaceuticals

NULL

Terminated

18 Years

N/A

Both

Phase 2

Czech Republic;Denmark;Hungary;Latvia;Poland;Russian Federation;Sweden